Trial
NCT01138137
N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
OHSU Knight Cancer Institute
Collaborators
—
Condition
Ovarian Carcinoma, Stage 3 or 4
Intervention
Paclitaxel
Why stopped
No funding was available for the cost of the IV N-acetylcysteine (NAC).
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-04-21